Price transparency alone cannot curb exploitative billing in private hospitals. Discuss with reference to Rule 9 of the Clinical Establishments Rules, 2012 and judicial interventions.

Rule 9 of the Clinical Establishments (Central Government) Rules, 2012 gives hospitals two duties. They must display their rates in the local language and English, and they must charge within a range of rates that the Centre fixes with the States [2]. The Centre's October 2026 advisory enforces only the first duty [1]. Showing a price without capping it leaves patients exposed.

Rule 9: Disclosure vs Price Control

• Rule 9(i) requires rates to be displayed at a conspicuous place. This is a condition for registration and for keeping it [2].
• Rule 9(ii) requires a range of rates. A subcommittee of the National Council was set up to define it [3], but no range has been notified even a decade later.
• So a hospital can display a very high rate and still be fully compliant.

Why Transparency Alone Falls Short

• Information asymmetry: an accident or cardiac patient cannot compare hospitals. The doctor decides both what treatment is needed and what it costs.
• Bill inflation through add-ons: under PM-JAY, high-end drugs, consumables and diagnostics had to be separated from the per-day bed cost [4]. Rate boards that list only room charges hide these items.
• Financial burden: out-of-pocket spending was still 39.4% of total health expenditure in 2021-22 [5]. Families need cost certainty, not just information.
• Federal patchwork: health is a State subject, so the Centre can only "urge" [1]. States that have not adopted the Act follow their own laws, such as Maharashtra's 2026 Bill [6].

Judicial Interventions

• In Veterans Forum for Transparency in Public Life v. Union of India (2022), the Supreme Court held that fixing the range of rates is the Centre's duty, even though States implement the rules. It imposed costs of ₹20,000 [2].
• The case moved the debate from disclosure to price regulation. However, courts can only push the executive. Setting the actual rates remains an executive task.

Way Forward

• Notify the Rule 9(ii) range using PM-JAY packages as the base. HBP 2022 already prices procedures by city type and level of care, and it raised rates for 832 procedures [4].
• Require itemised rate lists that name charges for consumables and tests. District authorities should check them when registrations are renewed.
• States with their own laws should copy Rule 9. Maharashtra's Bill already bars charging above displayed rates and requires itemised bills [6].

Rate display is a necessary first step, but it is not enough. A regularly revised range of rates, as the Supreme Court directed, and enforcement by the States can turn transparency into real protection for patients. This would advance Article 47's public-health mandate and SDG 3.8 on financial protection in healthcare.